Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

2.62
Delayed Data
As of Jul 31
 +0.40 / +18.02%
Today’s Change
0.66
Today|||52-Week Range
2.90
+194.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues303.8K201.0K220.5K361.8K
 
 
 
 
 
Cost of Goods Sold125.6K66.9K83.0K154.1K
 
 
 
 
 
Depreciation And Amortization6.8K6.8K7.5K13.9K
 
 
 
 
 
 
Operating ExpensesGross Income171.3K127.3K130.0K193.8K
 
 
 
 
 
General Expenses2.1M1.2M1.4M1.5M
 
 
 
 
 
Research And Development903.3K597.0K548.2K676.6K
 
 
 
 
 
Total Operating Expenses2.2M1.2M1.5M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.9M-1.0M-1.2M-1.3M
 
 
 
 
 
Interest Expense On Debt980.001.3K1.2K606.00
 
 
 
 
 
Other Expenses-1.7K-2.0K-49.00-504.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-1.0M-1.2M-1.3M
 
 
 
 
 
Net Income-1.9M-1.0M-1.2M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.1M36.2M36.2M36.2M
 
 
 
 
 
Shares To Calculate EPS Diluted36.1M36.2M36.2M36.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.03-$0.03-$0.04
 
 
 
 
 
EPS Diluted-$0.05-$0.03-$0.03-$0.04